← SynDRA
(2E,3S)-2-benzylidene-3-(cyclohexylamino)-3H-inden-1-one
SynDRA canonical compound SYN0709470 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MAPK3 |
|---|
| Mechanism of action | MAP kinase phosphatase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Protein phosphatase inhibitor
- MAP kinase phosphatase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CBX1
- ERG
- GLP1R
- LMNA
- NFE2L2
- TARDBP
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- NCGC00014399
- NSC-150117
- NCGC00014399-02
- NCGC00097506-01
- XJDKPLZUXCIMIS-UHFFFAOYSA-N
- CID-5458317
- 2-benzylidene-3-(cyclohexylamino)-3H-inden-1-one
- QAA98284
- 2-benzylidene-3-(cyclohexylamino)-1-indanone
- 3-(cyclohexylamino)-2-(phenylmethylene)-3H-inden-1-one
- NSC150117
- SCHEMBL3698122
- NCI60_001042
- (E)-BCI
- G90870
- bci-hydrochloride
- C22H23NO
- orb1309724
- Dual Specificity Protein Phosphatase 1/6 Inhibitor
- VZB79251
- 2-Benzylidene-3-cyclohexylamino-indan-1-one
- BCI(NSC 150117)?
- CHEBI:94321
- s2837
- (2E)-2-benzylidene-3-(cyclohexylamino)indan-1-one
- T10486
- BS-45661
- BRD-A08840375-001-01-3
- E73445
- orb1309939
- CHEBI:143126
- EX-A4288
- SCHEMBL30461402
- BDBM50326052
- (2E)-2-benzylidene-3-(cyclohexylamino)-3H-inden-1-one
- T11139
- (2E)-2-Benzylidene-3-(cyclohexylamino)-1-indanone
- 2-benzylidene-3-(cyclohexylamino)indan-1-one
- RefChem:909662
Look up (2E,3S)-2-benzylidene-3-(cyclohexylamino)-3H-inden-1-one in the interactive SynDRA portal →